TY - JOUR
T1 - Native LDL-induced oxidative stress in human proximal tubular cells
T2 - Multiple players involved
AU - Piccoli, Claudia
AU - Quarato, Giovanni
AU - D'Aprile, Annamaria
AU - Montemurno, Eustacchio
AU - Scrima, Rosella
AU - Ripoli, Maria
AU - Gomaraschi, Monica
AU - Cirillo, Pietro
AU - Boffoli, Domenico
AU - Calabresi, Laura
AU - Gesualdo, Loreto
AU - Capitanio, Nazzareno
PY - 2011/2
Y1 - 2011/2
N2 - Dyslipidemia is a well-established condition proved to accelerate the progression of chronic kidney disease leading to tubulo-interstitial injury. However, the molecular aspects of the dyslipidemia-induced renal damage have not been fully clarified and in particular the role played by low-density lipoproteins (LDLs). This study aimed to examine the effects of native non-oxidized LDL on cellular oxidative metabolism in cultured human proximal tubular cells. By means of confocal microscopy imaging combined to respirometric and enzymatic assays it is shown that purified native LDL caused a marked increase of cellular reactive oxygen species (ROS) production, which was mediated by activation of NADPH oxidase(s) and by mitochondrial dysfunction by means of a ROS-induced ROS release mechanism. The LDL-dependent mitochondrial alterations comprised inhibition of the respiratory chain activity, enhanced ROS production, uncoupling of the oxidative phosphorylation efficiency, collapse of the mtΔΨ, increased Ca
2+ uptake and loss of cytochrome c. All the above LDL-induced effects were completely abrogated by chelating extracellular Ca
2+ as well as by inhibition of the Ca
2+-activated cytoplas-mic phospholipase A2, NADPH oxidase and mitochondrial permeability transition. We propose a mechanicistic model whereby the LDL-induced intracellular redox unbalance is triggered by a Ca
2+ inward flux-dependent commencement of cPLA2 followed by activation of a lipid- and ROS-based cross-talking signalling pathway. This involves first oxidants production via the plasmamembrane NADPH oxidase and then propagates downstream to mitochondria eliciting redox- and Ca
2+-dependent dysfunctions leading to cell-harming conditions. These findings may help to clarify the mechanism of dyslipidemia-induced renal damage and suggest new potential targets for specific therapeutic strategies to prevent oxidative stress implicated in kidney diseases.
AB - Dyslipidemia is a well-established condition proved to accelerate the progression of chronic kidney disease leading to tubulo-interstitial injury. However, the molecular aspects of the dyslipidemia-induced renal damage have not been fully clarified and in particular the role played by low-density lipoproteins (LDLs). This study aimed to examine the effects of native non-oxidized LDL on cellular oxidative metabolism in cultured human proximal tubular cells. By means of confocal microscopy imaging combined to respirometric and enzymatic assays it is shown that purified native LDL caused a marked increase of cellular reactive oxygen species (ROS) production, which was mediated by activation of NADPH oxidase(s) and by mitochondrial dysfunction by means of a ROS-induced ROS release mechanism. The LDL-dependent mitochondrial alterations comprised inhibition of the respiratory chain activity, enhanced ROS production, uncoupling of the oxidative phosphorylation efficiency, collapse of the mtΔΨ, increased Ca
2+ uptake and loss of cytochrome c. All the above LDL-induced effects were completely abrogated by chelating extracellular Ca
2+ as well as by inhibition of the Ca
2+-activated cytoplas-mic phospholipase A2, NADPH oxidase and mitochondrial permeability transition. We propose a mechanicistic model whereby the LDL-induced intracellular redox unbalance is triggered by a Ca
2+ inward flux-dependent commencement of cPLA2 followed by activation of a lipid- and ROS-based cross-talking signalling pathway. This involves first oxidants production via the plasmamembrane NADPH oxidase and then propagates downstream to mitochondria eliciting redox- and Ca
2+-dependent dysfunctions leading to cell-harming conditions. These findings may help to clarify the mechanism of dyslipidemia-induced renal damage and suggest new potential targets for specific therapeutic strategies to prevent oxidative stress implicated in kidney diseases.
KW - Chronic kidney disease
KW - Cytoplasmic phospholipase A2
KW - Kidney proximal tubular cells
KW - Lipid signalling
KW - Low density lipoproteins
KW - Mitochondria
KW - NADPH oxidase
KW - Reactive oxygen species
KW - Redox signalling
KW - ROS-induced ROS release
UR - http://www.scopus.com/inward/record.url?scp=79951909095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951909095&partnerID=8YFLogxK
U2 - 10.1111/j.1582-4934.2009.00946.x
DO - 10.1111/j.1582-4934.2009.00946.x
M3 - Article
C2 - 19863698
AN - SCOPUS:79951909095
VL - 15
SP - 375
EP - 395
JO - Journal of Cellular and Molecular Medicine
JF - Journal of Cellular and Molecular Medicine
SN - 1582-1838
IS - 2
ER -